Literature DB >> 15207312

Tularemia: the disease and the weapon.

Steven D Cronquist1.   

Abstract

Tularemia is a bacterial infection usually transmitted via arthropod vectors or direct contact with infected animals. Naturally occurring cases are relatively rare, and can result in six different clinical syndromes. Tularemia is also a potential agent of bioterrorism or biowarfare, and is categorized as a high-level threat. Effective antibiotic treatment is available, including potential use of oral antibiotics in a mass casualty situation. An awareness of potential clinical presentations of tularemia will facilitate timely intervention,appropriate diagnostic testing, and decreased morbidity in the event of a biologic attack with Francisella tularensis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15207312     DOI: 10.1016/j.det.2004.03.009

Source DB:  PubMed          Journal:  Dermatol Clin        ISSN: 0733-8635            Impact factor:   3.478


  10 in total

1.  Identification of Francisella tularensis genes affected by iron limitation.

Authors:  Kaiping Deng; Robert J Blick; Wei Liu; Eric J Hansen
Journal:  Infect Immun       Date:  2006-07       Impact factor: 3.441

Review 2.  Tularemia: a rare cause of neck mass, evaluation of 33 patients.

Authors:  Sedat Cağlı; Alperen Vural; Onur Sönmez; Imdat Yüce; Ercihan Güney
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-08-04       Impact factor: 2.503

3.  [Tularemia lymphadenitis. An emerging differential diagnosis of necrotizing granulomatous cervical lymphadenitis].

Authors:  J Strehl; C Schoerner; A Hartmann; A Agaimy
Journal:  Pathologe       Date:  2014-03       Impact factor: 1.011

4.  Characterization of a Unique Outer Membrane Protein Required for Oxidative Stress Resistance and Virulence of Francisella tularensis.

Authors:  Maha Alqahtani; Zhuo Ma; Harshada Ketkar; Ragavan Varadharajan Suresh; Meenakshi Malik; Chandra Shekhar Bakshi
Journal:  J Bacteriol       Date:  2018-03-26       Impact factor: 3.490

Review 5.  Humoral and cell-mediated immunity to the intracellular pathogen Francisella tularensis.

Authors:  Girish S Kirimanjeswara; Sofia Olmos; Chandra S Bakshi; Dennis W Metzger
Journal:  Immunol Rev       Date:  2008-10       Impact factor: 12.988

6.  Respiratory Francisella tularensis live vaccine strain infection induces Th17 cells and prostaglandin E2, which inhibits generation of gamma interferon-positive T cells.

Authors:  Matthew D Woolard; Lucinda L Hensley; Thomas H Kawula; Jeffrey A Frelinger
Journal:  Infect Immun       Date:  2008-04-07       Impact factor: 3.441

Review 7.  Treatment of neuroterrorism.

Authors:  Katharina M Busl; Thomas P Bleck
Journal:  Neurotherapeutics       Date:  2012-01       Impact factor: 7.620

8.  An Improved Tobacco Mosaic Virus (TMV)-Conjugated Multiantigen Subunit Vaccine Against Respiratory Tularemia.

Authors:  Ahd A Mansour; Sukalyani Banik; Ragavan V Suresh; Hardeep Kaur; Meenakshi Malik; Alison A McCormick; Chandra S Bakshi
Journal:  Front Microbiol       Date:  2018-06-05       Impact factor: 5.640

Review 9.  Biowarfare and bioterrorism.

Authors:  Michael D Christian
Journal:  Crit Care Clin       Date:  2013-07       Impact factor: 3.598

10.  Identification of a live attenuated vaccine candidate for tularemia prophylaxis.

Authors:  Manish Mahawar; Seham M Rabadi; Sukalyani Banik; Sally V Catlett; Dennis W Metzger; Meenakshi Malik; Chandra Shekhar Bakshi
Journal:  PLoS One       Date:  2013-04-17       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.